Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.8136
-0.0576 (-6.61%)
At close: May 15, 2026, 4:00 PM EDT
0.8100
-0.0036 (-0.44%)
Pre-market: May 18, 2026, 5:12 AM EDT
Skye Bioscience Stock Forecast
SKYE's stock price has decreased by -57.18% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 8 analysts polled by S&P Global, Skye Bioscience stock has a consensus rating of "Buy" and an average price target of $7.71. The average 1-year stock price forecast is 847.64% higher than the current stock price, while the lowest is $2.00 (+145.82%) and the highest is $20 (+2,358.21%).
Price Target: $7.71 (+847.64%)
Analyst Consensus: Buy
* Price targets were last updated on Sep 30, 2025.
Analyst Ratings
The average analyst rating for Skye Bioscience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +2,358.21% | Sep 30, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $10 | Buy | Initiates | $10 | +1,129.11% | Aug 15, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +1,743.66% | Jun 24, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +1,620.75% | Mar 21, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $15 | Buy | Reiterates | $15 | +1,743.66% | Mar 21, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.98
from -1.41
EPS Next Year
-1.13
from -0.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.62 | -0.61 | ||||||
| Avg | -0.98 | -1.13 | ||||||
| Low | -1.41 | -1.68 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.